Muna Bhanji, R.Ph

Muna has served on Ardelyx’s board of directors since March 2021. Muna has served as the founder and principal of Tiba Global Access, LLC, an independent senior advisory practice focused on commercialization and market access strategy development, since January 2021. She previously held roles of increasing responsibility at Merck & Co. between 1986 and January 2021. Most recently, Muna served as senior vice president, global market access and as senior vice president, hospital & specialty franchises from.

She currently serves on the boards of directors of Veracyte, Cytokinetics, Intellia Therapeutics, Lumanity, and Corus International, an international humanitarian organization committed to poverty alleviation.

Muna received her B.Sc. in Pharmacy from the Rutgers School of Pharmacy, and her M.B.A. from Saint Joseph’s University.